Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Ixekizumab + Tirzepatide for Psoriasis
Recruiting2 awardsPhase 3
Birmingham, Alabama
This trial aims to show that when people with moderate to severe plaque psoriasis and obesity or overweight are given ixekizumab and tirzepatide together, their psoriasis improves and they
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.